SFBC International to Present at the UBS Global Healthcare Services Conference at 1 p.m. ET on Monday, February 13, 2006; Webcas

SFBC International, Inc. (NASDAQ: SFCC), a provider of
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies, today announced that
Jeffrey P. McMullen, chief executive officer of SFBC International,
will present at the UBS Global Healthcare Services Conference at 1
p.m. ET on Monday, February 13, 2006. The conference will take place
at The Grand Hyatt in New York City.
   All interested parties can access a live audio Webcast of the
presentation through the "Webcasts" section of SFBC's Web site at
www.sfbci.com. The replay of the Webcast will be available 3 hours
after the actual presentation time, and will be available until March
15, 2006.

   About SFBC International, Inc.

   SFBC International, Inc. provides early and late stage clinical
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies around the world. SFBC has
more than 30 offices located in North America, Europe (including
Central and Eastern Europe), South America, Asia, and Australia. In
early clinical development services, SFBC specializes primarily in the
areas of Phase I and early Phase II clinical trials and bioanalytical
laboratory services, including early clinical pharmacology. SFBC also
provides late stage clinical development services globally that focus
on Phase II through IV clinical trials. SFBC also offers a range of
complementary services, including data management and biostatistics,
central laboratory services, medical and scientific affairs,
regulatory affairs and submissions, and clinical IT solutions.
Additional information is available on SFBC's website at
www.sfbci.com.